chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two days post vax pt developed cellulitis left thigh for 48 hours. Pt treated with Diclox, Tylenol. Pt to follow on 08/22/2000.
Half baseball size swelling under arm of left injection site arm, swelling lasted 2 days.  Iced area under arm and held away from body with small pillow to due to rawness of area. Additionally fever of 100.4 at highest over 2 days.  Chills from 12-24 hours after injection.
ringing in ear; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in ear) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (ringing in ear). At the time of the report, TINNITUS (ringing in ear) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-071246, MOD21-072080 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071246: MOD21-072080:
Patient received #5 DTaP on 4/20/04. Patient left deltoid is swollen, itchy and red. Mom states signs and symptoms started 24 hours after vaccines were administered. Other vaccines given the same day were IPV and HAV. .
Symptoms: erythematous, size of golfball, raised, sore. Tx: pt instructed to put ice on site (off and on today) use antiinflammatories (Motrin) prn, take Benadryl prn for allergic Rx.
kind of achy all over the body; Headaches; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (kind of achy all over the body), HEADACHE (Headaches) and PYREXIA (low grade fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032F21A, 002A21A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced PAIN (kind of achy all over the body), HEADACHE (Headaches) and PYREXIA (low grade fever). At the time of the report, PAIN (kind of achy all over the body), HEADACHE (Headaches) and PYREXIA (low grade fever) had not resolved.            No concomitant medications were reported. No treatment medications were reported.
Redness at injection site, swollen and left arm felt heavy, cold pack applied 1:50pm BENADRYL 25 mg given by mouth and ADVIL 200 mg by mouth for pain.
Pain first, no pain at injection site, pain upper arm all over. Then about one hour later I looked at arm and it had like a pancake shaped raised about 3/4in and round dark red spot upper bicep. Lots of pain and got worse as the night went on did not sleep from pain took a BENADRYL 25mg over the counter and two aspirin to see if I could sleep to no avail. In the morning at 9:00 called to see who would be able to see me at my doctor's office my doc was busy so I saw someone else in that group. He gave me prednisone 10mgs 4 one day 3 the next and so forth. Not enough it is moving around. The huge red spot. Yes I do not have so much pain that I cannot move my arm so it is getting better very slow. It also gave me pain upper arm and right side shoulder close to my neck and really hot to the touch.
Sight soreness in throat; A spontaneous report was received from a consumer concerning an 73-year-old female, who received Moderna's COVID-19 vaccine (mRNA-1273), and experienced slight soreness in throat.  The patient's medical history was not reported. No concomitant medications were reported.  On 12 FEB  2021 prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (batch- lot number 024M20A), intramuscularly in the arm for the prophylaxis of COVID-19 infection.  On 23 FEB 2021, it was reported that the patient experienced slight soreness in her throat (it's not a bad sore throat).     Action taken with second dose of mRNA-1273 is unknown.  The outcome of the event, slight soreness in throat was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Arm soreness, fever (101.5F), chills, rigors, headache, and body aches. The fever and chills were refractory to ibuprofen and required both ibuprofen and Tylenol to break. The fever and chills continued for 24 hours and the headache/body aches continued for 36 hours, the arm soreness has improved but is ongoing.
Case number PHEH2011US02085 is an initial spontaneous report received from a consumer 18 Aug 2011 with a follow-up received from the consumer on 22 Nov 2011: This report refers to a 58-year-old female patient. She was vaccinated with FLUVIRIN (batch number: 111808P1) on 15 Oct 2010. On the same day, four to five hours after vaccination, she began to experience heaviness on the left side of her head and face "like it was full of water". Her left side started to vibrate and it went into her inner right leg. The shot was administered on her left side and it somehow attacked her central nervous system. She said it felt like hot lava was poured in side of her. She had to sleep sitting up in a chair. She saw a neurologist and he couldn't do anything for her. She now had a new doctor who was trying to help. She was not taking any other concomitant medications. The patient said this experience made it horrible for her to live this way. The vibration she was feeling had not stopped from the time she received the shot. She also had problems with periodic numbness and tingling on the left side of her body. No further information was provided. Follow-up received from the consumer on 22 Nov 2011: Updated events and outcome.
Diverticulitis with diarrhea, chills.   Treated with antibiotics;   lasted 3 days.
On the first day after vaccination, patient experienced severe joint pain, mostly in his hands and arms. Then by the second day a rash had started to spread up his hands, arms, onto his head, scalp and back. He reported no chest rash but stated it is still growing. Red, raised bumps that are very itchy. Reported to me on day 4 post-vaccination 11/10/19.
Menstruation came about 14 days early and is heavier than normal. Tight feeling in the chest.
WAS UNABLE TO MOVE ARM ON SUNDAY MORNING AND WAS RED AND SWOLLEN, SO HE WENT TO THE DOCTOR'S OFFICE AND THEY DIAGNOSED IT AS CELLULITIS AND GAVE HIM DOXYCYCLINE.
Started with spike in Blood Pressure to 180/110.  Progressed to Dysarthria, Dysphagia, Increased and Irregular Heartbeat, Increased Repirations, Dizzy, and Fatigue.  Went to ER on 10/21.  Diagnostic tests ruled out Stroke, TIA, and Heart Attack.  Released for Outpatient Follow Ups and additional Testing indicated below.  All symptoms except Dysarthia & Dysphagia improved within several weeks.  Dysarthia & Dysphagia improving in Dec after starting Pyridostigmine for Myasthenia Gravis.  (No prior history of MG and no family history.) Symptoms were very slow in progressing for days.  Listed in when it became very evident.  Not sure which doctor is best.  Have names for Family/General Practice, ER doctor, Cardiologists, Otolarygologist, Neurologiests, etc.  Also available to me are doctor notes that appear in software.
This spontaneous report as received from a consumer regarding a 11 year old female patient. The patient's concurrent conditions and relevant medical history was not reported. The patient had no drug allergies/reactions or pertinent medical history. On 17-JUL-2014, the patient was vaccinated with first dose of GARDASIL (lot number, dose and frequency unspecified) in the arm. Concomitant therapies included Tdap. Approximately on an unknown date in September 2014 (reported as two months after vaccination with GARDASIL), the patient experienced alopecia. The patient was treated with unspecified topical corticosteroids. The patient sought medical attention. The patient undergone unspecified blood work of which results were not provided. The outcome of alopecia was reported as not recovered/not resolved. The causality of the events with GARDASIL vaccine was not reported. Product quality issue was not involved. Additional information has been requested.
consumer reports that pt exp a convuls the day p/vax was administered; taken to ER; pt had a virus @ time of vax; no fever; h/o convuls during ear infect @ 1 yr old; had shock-like event p/1st DTP &  IG reflux p/2nd DTP;
Information has been received from a health professional concerning a 25 year old female who was vaccinated with Gardasil. Subsequently the patient experienced injection site pain and the site was bruised. Additional information has been requested.
pain at the injection site; received the first dose of Shingrix via subcutaneous route; This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number 22S3B, expiry date 25th March 2022) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (subcutaneous). On an unknown date, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional information was provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. Nurse reported that 17 patients received the first dose of Shingrix via subcutaneous route, which led to intramuscular formulation administered by other route. Some of them were female patients. Nurse did not provide initials, date of birth, lot number and expiration dates of the vaccines. She did not said how many patients were male and how many were female. This is 1 of the 17 cases, reported by same reporter.   Follow up information received from nurse on 3rd April 2020 as follows: The patient's demographic details were updated. The batch number updated for the suspect vaccine. The patient's past medical history included hypertension, hyperthyroidism, stress incontinence (small) and osteoarthritis, it was ongoing at the time of reporting.  On 16th January 2020, the patient received the 1st dose of Shingrix  .5 ml. On 16th January 2020, less than a day after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.  It was unknown if the reporter considered the injection site pain to be related to Shingrix. The VAERS details were updated.
Patient is a 80 y.o. female with a history of atrial fibrillation on Eliquis, HFpEF, CKD, COPD and recent admission to Hospital 3/14/23 - 3/20/23 for COVID pneumonia who presented to Hospital 3/23/23 due to hemoptysis and recurrent dyspnea. There she developed progressive hypoxia to 10L O2. She was given CAP coverage azithromycin/Rocephin and deteriorated to requiring continuous BiPAP prior to transfer.  She was transferred to 3/24/2023 and arrived in respiratory distress and unresponsive to stimuli with copious congealed blood suctioned from the oropharynx. Made DNR CC 3/25/2023. Patient passed away 3/26/2023.        1. Acute Hypoxic Respiratory Failure: Patient requiring HHFNC for adequate oxygenation. Progressive decompensation since presentation 3/23/23, thought previously diagnosed with COVID 3/14/23 treated with Decadron 3/14 - 3/20/23. In setting of COVID, hemoptysis, and likely aspiration. Made DNR CC 3/25/2023. Comfort meds being used. Patient passed away 3/26/2023. 2. Acute Metabolic Encephalopathy: Acute onset AMS, after patient gave a history at hospital. Currently obtunded, not protecting airway with gag only to deep suction. CT head unlikely to change management.  3. Hemoptysis: Copious blood suctioned from oropharynx on arrival after report of hemoptysis 3/23/23 that reportedly resolved. 1x PCC dose given on admit.  4. Atrial fibrillation with RVR: Noted uncontrolled rate despite Cardizem drip.  Also with frequent PVCs. To discontinue rate controlling measures given DNR CC.  5. Severe Sepsis: AMS with leukocytosis, lactic acidosis and acidemia. 6. COVID Pneumonia: Diagnosed 3/14/23 after reporting a couple weeks of cough. S/p Decadron and Remdesivir treatment. 7. Chronic HFpEF: TTE 3/15/23 low normal systolic function with EF 50%, mild MR. Hypovolemic. 8. Coagulopathy: Unknown prior last dose of Eliquis, held further. Rising INR since last result at hospital concerning for multiorgan failure. Kcentra trial. 9. Code status: DNR CC, confirmed 3/25/2023 10. DVT Prophylaxis: Not indicated
Information has been received from a physician assistant concerning a 21 year old female who on 25-NOV-2007 was vaccinated with a dose of GARDASIL and on 22-JAN-2008 was vaccinated with a dose of GARDASIL.  There was no concomitant medication.  On 11-MAR-2008 false positive on a HIV test.  An HIV test was done on 11-MAR-2008 that was positive which mandates an automatic confirmation test to be done that same day which was negative.  The confirmation test is more in depth and accurate so the patient was not HIV positive.  Medical attention was sought in the office.  Patient's outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
Reported through facility intelligence report: arm sore like a tetanus booster. Came to employee health 11.24.14. Referred to PM&R. Limited movement, chronic pain, intermittent numbness.
Employee states she had low grade temp after the vaccine. The day after vaccination (1/27/21) her heart rate was between 140-150 and she described feeling she was short of breath. She was seen at an urgent care where an EKG was done  and she was given 1 Liter of fluid. Employee feels better today and is resting at home. She says her HR was around 110 while resting in bed at home. She states she no longer has a fever.
Rash; Headache; Fever; Chills; Chest pain; This is a spontaneous report from a contactable consumer. This consumer reported for male patient (reporter's son). A 17-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE; formulation: solution for injection, Batch/Lot Number and expiry date was not reported), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE; formulation: solution for injection, Batch/Lot Number and expiry date was not reported), dose 1 via an unspecified route of administration on an unspecified date (at the age of 17-years-old) as DOSE 1, SINGLE for COVID-19 immunization. On an unspecified date the patient after the second shot, experienced rash, headache, fever, chills, and chest pain. Reported said, he (patient) just got second shot of vaccine last Saturday. He had side effects like rash, headache, fever, chills that comes with it but now, he was complaining about his chest, he had a chest pain. Is that normal? The strange thing is that he is having this now, is that normal after two days?" The reporter had to go and check whether the patient was feeling better. The patient underwent lab tests and procedures which included body temperature, fever on an unspecified date. Reporter seriousness for all the events were unspecified. The clinical outcome of the events was unknown.  Information about lot/batch number has been requested.  No follow-up attempts are completed; information about lot/batch number cannot be obtained.
1s dose of Shingrix and experienced arm pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included hypersensitivity.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, after vaccinaion experienced arm pain. The consented to follow up. For tolerence of 2nd dose refer case US2020044415, reported by same reporter. This was 1 of 3 cases reported by same reporter.
At about 02:30 the next morning, on the 9th, I woke myself up with my teeth chattering. I couldn't stop my teeth from chattering. I wasn't cold or feel cold. I wasn't cold to the touch. I wasn't running a fever. Put on an additional blanket. I was awake about an hour and 15 minutes with it. I fell back asleep. I was fine when I woke up the next morning. I do have dental implants. Because of the rods, when my face were chattering, it was loud enough to wake me up. I have never had that before. I have been chilled before, but I didn't feel cold this time. I did have a flu shot as the same time as the booster but in a different arm. I was a little bit sore the next day but my arm wasn't too bad. It was just a little achy but my flu shot arm felt more stiff and sore than the COVID 3rd dose arm felt.
Information has been received from a physician concerning an adult female who was vaccinated on 11/15/90. In January 2001, the patient experienced pneumococcal sepsis. The patient was admitted to the hospital on approximately 01/19/01. She was diagnosed with pneumococcal sepsis of 9N followed by pneumothorax. The patient was placed on a ventilator for one week. She experienced kidney shut down. She experienced no urinary output for 36 hours. Blood pressure was 30/0. There was a secondary diagnosis of lupus. The patient was receiving large doses of Prednisone. The patient was very weak. An anticipated date of discharge was unknown. The patient's symptoms persisted at the time of the report, and she remained hospitalized. It was reported she would require extensive rehabilitation. No further information is available. Follow-up from a physician concerning an adult female "in her 30's" who in 11/99 was vaccinated with pneumococcal vaccine 23 polyvalent (lot 629633/1993H). The pt had received pneumococcal vaccine 23 polyvalent (Pnu-Imune, lot 285908) on 11/15/90. On approx. 1/17/01, the pt was seen as an outpt for wheezing and asthma and was treated with pulse steroids. On approx. 1/19/01, she was admitted to the hospital with bacterial sepsis. She was very hypotensive in the ER with a systolic blood pressure in the 30's. She was treated with dobutamine and dopamine. The pt's symptoms persisted at the time of the report and she remained hospitalized. It was reported she would require extensive rehabilitation. Follow-up was received which indicated she was extubated and discharged to a nursing rehabilitation facility on approx. 2/13/01. The pt was improving very slowly with no use of her legs at this point and only functional use of her upper extremities. The bacterial sepsis was found to be secondary to S. pneumoniae type 9N. No further information is available.
Information has been received from a physician, via a company representative, concerning a female patient who in January 2007, was vaccinated IM in the deltoid, with a dose, 0.5ml, of Gardasil. In January 2007, the patient developed a "large circular size welt at the injection site." At the time of this report, it was unknown if the patient had recovered. The patient sought unspecified medical attention. Additional information has been requested.
Sore/swollen lymph nodes on the side of injection, very vivid dreams, restlessness, significant increase in  anxiety/panic attacks, hard time falling asleep
Nausea, heart palpitations, weakness in limbs, blurry vision, confusion, hallucinations.
I had a mammogram in June 1, 2021 and breast MRI. Doctors found radial scars.  I had stereotactic biopsies done July 12, 2021 and it came back benign.  I went back in for mammogram June 2022. I still have the radial scars and there is concern.  I will have another biopsy  on the right breast Monday, July 18, 2022.  There is pain in both breasts.
passed out in my car while i was driving on the highway.  woke up in my car in the ditch
Swolen lymph nodes under left arm. Slightly painfull and uncomfortable,still occurring. Noticed this when I woke this morning . I also felt ill the day after the shot with painfull joints overall body weakness, headache and fatigue which lasted 24 hours and was helped by Tylenol and sleep.
swollen and rash at injection site, aching arm for 2 weeks, low grade fever and body aches and headache the night the vaccine was administered,  what looks like covid toes 8 days after vaccine
no adverse effects; patient received improperly stored vaccine / Temperature: 37.9F; This spontaneous report as received from a medical assistant refers to a 10-year-old male patient. No information regarding the patient's pertinent medical history and drug reactions or allergies. The patient's concomitant therapies included hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) and influenza virus split virion 3v vaccine inactivated (FLUVAX).     On an unknown date, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) (dose, route of administration, lot # and expiration date were not reported) for prophylaxis. On 12-FEB-2021, the patient was vaccinated with the second dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 1 dose, lot # S021322, expiration date 09-JUL-2021, in the right arm for prophylaxis (lot # also reported as 1006345, expiration date 20-FEB-2022, lot# 1006345 has been verified to be not valid for varicella virus vaccine live (oka/merck)). The administered vaccine experienced a temperature excursion of 37.9 F for 7 hours 12 minutes. There was no previous temperature excursion. The data logger was involved. No adverse effects was reported.
About 1 hour after immunization, patient complained of significant pain at the injection site and reported difficulty walking/moving her leg. Parent of child noticed a red welt around 6:00 pm that night, with the area of swelling being about the size of a softball. There was warmth at the injection site, which later developed into a bruise that is still persisting. Patient also developed a fever, increased sensitivity/pain at the injection site. Patient had difficulty walking/ moving the leg for about 5 days post injection.  Mother of child tried heat/ice application at the injection site, tried massaging/working out the injection site to disperse pain, patient elevated site with a pillow, pineapple juice to help reduce inflammation.
P/receiving a dose of Influenva vax, pt exp chills & fever; 2 wks later devel pain in arm which radiated down the arm & still persists; Reporter was unable to provide any additional info;
chief c/o weakness, back pain, flank pain, radiculitis, ataxic gait, paralumbar pain dx w/GBS: